PTCT Stock Analysis: Buy, Sell, or Hold?
PTCT - PTC Therapeutics, Inc.
$78.06
-3.27 (-4.02%)
▼
5d:
-12.49%
30d:
+4.48%
90d:
+10.85%
WAIT
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 06, 2026
21d
Get Alerted When PTCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PTCT is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PTCT is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$150.27
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$93.31
16.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PTCT is currently trading at $78.06, which is considered fair relative to its 30-day fair value range of $74.93 to $85.65. The stock's valuation (Forward PE: 25.3) is in line with its historical norms (27.2). Remarkably, the market is currently pricing in an annual earnings decline of 2.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PTCT is in a strong uptrend. The price is currently testing key support at $79.30. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $94.14 (+20.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PTCT is in a strong uptrend. The price is currently testing key support at $79.30. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $94.14 (+20.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$74.93 -
$85.65
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
67.6%
Protect Your Profits
Holding PTCT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 20.6% below Wall St target ($94.14)
- WARNING: Recommendation downgraded due to -12.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$74.93 -
$85.65
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$79.30
Resistance Level
$90.87
Current Trend
Strong Uptrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.29
Wall Street Target
$94.14
(+20.6%)
Revenue Growth (YoY)
-76.8%
Profit Margin
-22.6%
Valuation Discount vs History
-2.4% cheaper
PE vs Historical
25.3 vs 27.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.4%
(market-implied from PE analysis)
1-Year Target
$76.19
(-2%)
2-Year Target
$74.36
(-5%)
3-Year Target
$72.57
(-7%)
3-Yr Target (if PE normalizes)
(PE: 25→27)
$78.06
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.3, Growth: 107.2%)
$263.45
(+238%)
Base:
(SPY PE: 21.8, Growth: 107.2%)
$226.90
(+191%)
Bear:
(PE: 18.5, Growth: 107.2%)
$192.86
(+147%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.3 to 27.2
Stabilization Target:
$83.96
(+7.6%)
PE Expansion Potential:
+7.6%
Share & Embed Analysis
Last updated: July 14, 2026 11:10 PM ET
Data refreshes hourly during market hours. Next update: 12:10 AM
Data refreshes hourly during market hours. Next update: 12:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Matthew B Klein
SELL
2850 shares
2026-04-21
Mark Elliott Boulding
SELL
2265 shares
2026-04-06
Lee Scott Golden
SELL
829 shares
2026-04-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 52 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 62 BUY |
Advanced PTCT Option Strategies
Professional options setups generated by AI based on today's PTCT price and gamma walls.
